Diabetes, smartphones, and robots: how an ‘artificial pancreas’ might help people with type 2 diabetes and kidney failure 29 September 2021 Managing blood glucose levels in people living with type 2 diabetes and kidney failure has historically been challenging. Good news, from an unlikely source, may be on the horizon. A recent trial of an artificial pancreas has reported very positive results. The technology, usually associated with managing type 1 diabetes, involves an external device that is made up of three components: a glucose sensor, a computer algorithm used to calculate insulin dosages, and an insulin pump. This is then connected to your smartphone. The software on your smartphone sends signals to the insulin pump to adjust the dosage as required. The study, undertaken by the University of Cambridge and the University Hospital of Bern, Switzerland, shows that the use of an artificial pancreas device can safely and effectively help people with type 2 diabetes and kidney failure manage their blood glucose levels. The study found that people using the artificial pancreas spent an additional 3.5 hours a day in the target blood glucose range. The study also found that the benefits of the device improved over time, as the computer algorithm adapted to the unique needs of the wearer. An artificial pancreas should allow the wearer more freedom, as it means simpler management of blood glucose levels. At the end of the study, most users reported spending less time managing their diabetes, and less time being concerned about their blood glucose levels. Research leader Dr Charlotte Boughton from the University of Cambridge said: ‘Patients living with type 2 diabetes and kidney failure are a particularly vulnerable group and managing their condition – trying to prevent potentially dangerous highs or lows of blood sugar levels – can be a challenge. There’s a real unmet need for new approaches to help them manage their condition safely and effectively.’ Type 2 diabetes is a major cause of kidney failure, accounting for just under a third of kidney failure cases. Kidney failure increases the potential for hypoglycaemia and hyperglycaemia (extremely high or low blood glucose levels). Managing diabetes in people with both diabetes and kidney failure can be challenging. People who have experienced full kidney failure also require kidney dialysis—the regular process of removing excess water and toxins from the blood in people whose kidneys can no longer do this naturally. The device is now being developed for people with type 2 diabetes who do not require kidney dialysis. Read more Key points: Management of blood glucose levels in people with type 2 diabetes and kidney failure can be challengingThis ‘artificial pancreas’ could be extremely useful for blood glucose management in this demographicMost users reported less day-to-day concern about their blood glucose levels when using the device
News 26 August 2026 Deanne Minniecon appointed Adjunct Associate Professor, UQ Deanne Minniecon, Group Executive, Aboriginal and Torres Strait Islander Engagement, has been appointed as an Adjunct Associate Professor in the School of Public Health at the University of Queensland (UQ). Continue Reading
Media releases 14 August 2026 Beyond blood glucose: New national partnership to measure how Australians with diabetes are really doing For the first time, the Australian Unity Wellbeing Index will be used to build the most complete picture yet of how diabetes affects Australian’s lives beyond clinical outcomes and health system costs, thanks to a partnership between â¹ûÖ±²¥, Deakin University, and the Australian Unity Support Foundation.  Continue Reading
Media releases 13 August 2026 PMOS in spotlight for diabetes prevention A new partnership between â¹ûÖ±²¥ and the Medibank Better Health Research Hub will support Monash University to develop a primary care model to better detect and prevent type 2 diabetes in women living with polyendocrine metabolic ovarian syndrome (PMOS). Continue Reading